Roland Aschoff

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Eric L. Simpson, Rodney Sinclair, Seth Forman et al. · The Lancet · 2020 · 491 citations · Full text

Medicine, Dermatology, Immunology +14

Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis

Eric L. Simpson, Melinda Gooderham, Andreas Wollenberg et al. · JAMA Dermatology · 2023 · 143 citations · Full text

Medicine, Dermatology, Pharmacotherapy +17

A randomized, double‐blind, phase <scp>III</scp> , multicentre study to evaluate the safety and efficacy of <scp>BF</scp> ‐200 <scp>ALA</scp> (Ameluz ^® ) vs. placebo in the field‐directed treatment of mild‐to‐moderate actinic keratosis with photodynamic therapy (PDT) when using the <scp>BF</scp> ‐Rhodo <scp>LED</scp> ^® lamp

Uwe Reinhold, Thomas Dirschka, Rolf Ostendorf et al. · British Journal of Dermatology · 2016 · 92 citations · Full text

Medicine, Dermatology, Ophthalmology +14

A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy

C.A. Morton, R. Dominicus, Peter Radny et al. · British Journal of Dermatology · 2018 · 72 citations · Full text

Medicine, Dermatology, Oncology +13

A randomized, intraindividual, non‐inferiority, Phase <scp>III</scp> study comparing daylight photodynamic therapy with <scp>BF</scp>‐200 <scp>ALA</scp> gel and <scp>MAL</scp> cream for the treatment of actinic keratosis

Thomas Dirschka, S. Ekanayake‐Bohlig, R. Dominicus et al. · Journal of the European Academy of Dermatology and Venereology · 2018 · 60 citations · Full text

Medicine, Dermatology, Ophthalmology +15